Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.
about
The use of fibroblast growth factor 23 testing in patients with kidney disease.The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study.Vitamin D deficiency and essential hypertension.The therapeutic role of monocyte chemoattractant protein-1 in a renal tissue engineering strategy for diabetic patientsCardiovascular effects of cholecalciferol treatment in dialysis patients--a randomized controlled trial.Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats.Vitamin D status is not related to development of atrial fibrillation in the community.Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney diseaseVitamin D therapy in chronic kidney disease and end stage renal disease.Extraskeletal actions of vitamin D.The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.Vitamin D: roles in renal and cardiovascular protection.Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients.Molecular mechanism of vitamin D in the cardiovascular systemVitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and β-adrenergic activity.CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?Vitamin D and the heart.FGF23 modifies the relationship between vitamin D and cardiac remodeling.Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.Shining D' light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D.New roles for renin and prorenin in heart failure and cardiorenal crosstalk.Vitamin D receptor activation and cardiovascular disease.What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?Vitamin D supplements in chronic kidney disease.The protective role of vitamin D on the heart and the kidney.Mineral metabolism and cardiovascular disease in CKD.Severely vitamin D-deficient athletes present smaller hearts than sufficient athletes.1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation.Involvement of the Vitamin D Receptor in Energy Metabolism Revealed by Profiling of Lysine Succinylome of White Adipose Tissue.Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease.Cardioprotective effect of calcitriol on myocardial injury induced by isoproterenol in rats.Vitamin D protection from rat diabetic nephropathy is partly mediated through Klotho expression and renin-angiotensin inhibition.Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients.The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.The Vitamin D Receptor Activator Maxacalcitol Provides Cardioprotective Effects in Diabetes Mellitus.
P2860
Q33835743-3B3DEA0B-EF67-4A43-9159-C9306A07BBD7Q34059805-8D410BA8-DB0F-4E10-96D5-EC7B3A82DCECQ34496209-CF61BC2F-346F-424A-9445-FD8B57989EAAQ34603718-50253BC1-49F1-4CE6-B48F-D1E6E848AE83Q35128801-4879F48B-FE07-4326-8947-5B064AF8DD02Q35167070-08A4878D-0A93-41A1-ADF0-98A0B663FE7BQ35207725-42A1D750-770D-4883-BA03-EAB158C4BC15Q35210184-EA191617-FB61-4872-AA0D-386F48042CB4Q35758581-9514D2D2-DA7D-4B9F-B231-5BFB7E2F8296Q36138538-9F653DBD-F044-4A60-9EAE-3656740CF432Q36613869-8BDC12C7-E7F0-4A9B-BC95-901CD4B50AFCQ36614706-E06617FE-444D-4119-84E0-C5BF38E9BC51Q36802341-DDFC4E6D-CF72-4A90-A58D-5156CBB6DF6DQ36821166-204C19AC-9170-4ABD-8637-1566DC368A07Q37234733-BA93EBCF-A63D-41B3-85A9-0FA513C0B9EAQ37279085-EAF81BA3-2A03-4252-8E07-C35E7E70AB77Q37342339-933430B2-A79B-49AA-8219-587218D9DF4EQ37401743-D27520C6-8FC8-486D-A6EC-3DB206AD0FE7Q37690771-DF7B3210-9A6E-4C18-8798-AC007A0BD129Q37842680-3D18E953-69EE-47DA-9A02-20FF74C58010Q37893014-A1C7057D-8269-4D94-8BAE-2C75AC17AF18Q38069143-12A25F03-5417-49E1-AD44-F00E6058889CQ38150052-D8390BAB-E47D-4D0A-8A0D-0CE76CA6AAEBQ38554471-F241397D-7591-4190-A3A8-7814EDB8364BQ38991955-1463A19C-0EEA-44D9-BAA4-28C7711AB9B3Q39072097-312AF174-D30E-4BA2-89DF-5AF4D9D5672AQ39277994-6EE85EB1-3342-4379-ADED-3BC3AF9F90CDQ41872361-BA838A75-5551-454E-874A-C195D454051CQ42621071-AFDA9B68-4208-429F-A367-D9CDCF235EE8Q45373448-8442CFE0-AD73-4023-9232-221055564AADQ46138257-59D33CAB-2B1F-4AB8-B558-E4EF3DE34107Q47225498-B46DFDE2-9453-4F17-8AA1-30BEFDD957D1Q48047762-8D40C37A-334D-4927-A1A7-78CC695590F7Q50101289-F1340B10-26FC-4E37-8DAC-7E8727C65E5BQ50433834-57B74E2A-0E3A-4DAD-AAC0-6A5C10C1A196Q52146506-BAD01B6E-05D9-4C6F-9180-4C82323E2A7F
P2860
Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@ast
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@en
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@nl
type
label
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@ast
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@en
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@nl
prefLabel
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@ast
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@en
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@nl
P2093
P2860
P1476
Therapeutic effects of vitamin ...... ontaneously hypertensive rats.
@en
P2093
Gene H Kim
Ishir Bhan
Minjie Wei
Ravi Thadhani
P2860
P304
P356
10.2353/AJPATH.2010.091292
P407
P577
2010-07-08T00:00:00Z